| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |